|
Q3 FY2016
As of Jun 30, 2016
|
Q2 FY2016
As of Mar 31, 2016
|
Q1 FY2016
As of Dec 31, 2015
|
Q4 FY2015
As of Sep 30, 2015
|
Q3 FY2015
As of Jun 30, 2015
|
Q2 FY2015
As of Mar 31, 2015
|
Q1 FY2015
As of Dec 31, 2014
|
Q4 FY2014
As of Sep 30, 2014
|
Q3 FY2014
As of Jun 30, 2014
|
Q2 FY2014
As of Mar 31, 2014
|
Q1 FY2014
As of Dec 31, 2013
|
Q4 FY2013
As of Sep 30, 2013
|
Q3 FY2013
As of Jun 30, 2013
|
Q2 FY2013
As of Mar 31, 2013
|
Q1 FY2013
As of Dec 31, 2012
|
Q4 FY2012
As of Sep 30, 2012
|
Q3 FY2012
As of Jun 30, 2012
|
Q2 FY2012
As of Mar 31, 2012
|
Q1 FY2012
As of Dec 31, 2011
|
Q4 FY2011
As of Sep 30, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Inventories - Note G | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Held for sale - Note B | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Noncurrent assets | ||||||||||||||||||||
| Property, plant and equipment | ||||||||||||||||||||
| Cost | ||||||||||||||||||||
| Accumulated depreciation | ||||||||||||||||||||
| Net property, plant and equipment | ||||||||||||||||||||
| Goodwill - Note H | ||||||||||||||||||||
| Intangibles - Note H | ||||||||||||||||||||
| Restricted investments - Note F | ||||||||||||||||||||
| Asbestos insurance receivable - Note L | ||||||||||||||||||||
| Equity and other unconsolidated investments | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Held for sale - Note B | ||||||||||||||||||||
| Total noncurrent assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Short-term debt - Note I | ||||||||||||||||||||
| Current portion of long-term debt - Note I | ||||||||||||||||||||
| Trade and other payables | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Held for sale - Note B | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Noncurrent liabilities | ||||||||||||||||||||
| Long-term debt - Note I | ||||||||||||||||||||
| Employee benefit obligations - Note K | ||||||||||||||||||||
| Asbestos litigation reserve - Note L | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Held for sale - Note B | ||||||||||||||||||||
| Total noncurrent liabilities | ||||||||||||||||||||
| Common stock, par value $.01 per share, 200 million shares authorized, issued 67 million shares in 2015 and 70 million shares in 2014 | ||||||||||||||||||||
| Paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
